Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease

References

• NegewoNA, GibsonPG, McDonaldVM. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20:1160–1171. doi:10.1111/resp.1264226374280
   PubMed Web of Science ®Google Scholar
• DivoM, CoteC, de TorresJP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155–161. doi:10.1164/rccm.201201-0034OC22561964
   PubMed Web of Science ®Google Scholar
• CharlsonME, PompeiP, AlesKL, MacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• CharlsonME, CharlsonRE, PetersonJC, MarinopoulosSS, BriggsWM, HollenbergJP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61:1234–1240. doi:10.1016/j.jclinepi.2008.01.00618619805
   PubMed Web of Science ®Google Scholar
• MarinJM, CoteCG, DiazO, et al. Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med. 2011;105:916–921. doi:10.1016/j.rmed.2011.01.00721282050
   PubMed Web of Science ®Google Scholar
• ManninoDM, HiguchiK, YuT-C, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015;148:138–150. doi:10.1378/chest.14-243425675282
   PubMed Web of Science ®Google Scholar
• Simon-TuvalT, ScharfSM, MaimonN, Bernhard-ScharfBJ, ReuveniH, TarasiukA. Determinants of elevated healthcare utilization in patients with COPD. Respir Res. 2011;12:7. doi:10.1186/1465-9921-12-721232087
   PubMed Web of Science ®Google Scholar
• AlmagroP, CalboE, de EchaguïenAO, et al. Mortality after hospitalization for COPD. Chest. 2002;121:1441–1448. doi:10.1378/chest.121.5.144112006426
   PubMed Web of Science ®Google Scholar
• BuhrRG, ChenX, TashkinDP, OngMK. Readmissions For COPD and the Interaction of Hospital Type and Case Mix Comorbidity. D13 the Revolving Door: Copd Hospitalization and Readmission. American Thoracic Society; 2017:A7001–A.
   Google Scholar
• CelliBR, CoteCG, MarinJM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012. doi:10.1056/NEJMoa02132214999112
   PubMed Web of Science ®Google Scholar
• MarinJM, CarrizoSJ, CasanovaC, et al. Prediction of risk of COPD exacerbations by the BODE index. Respir Med. 2009;103:373–378. doi:10.1016/j.rmed.2008.10.00419013781
   PubMed Web of Science ®Google Scholar
• CoteC, CelliB. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J. 2005;26:630–636. doi:10.1183/09031936.05.0004550516204593
   PubMed Web of Science ®Google Scholar
• OngK-C, EarnestA, LuS-J. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005;128:3810–3816. doi:10.1378/chest.128.6.381016354849
   PubMed Web of Science ®Google Scholar
• Disease GIfCOL. Global strategy for diagnosis, management and prevention of COPD (2015 update). 2015.
   Google Scholar
• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• BarnesP, CelliB. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–1185. doi:10.1183/09031936.0012800819407051
   PubMed Web of Science ®Google Scholar
• FreiA, MuggensturmP, PutchaN, et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014;67:904–911. doi:10.1016/j.jclinepi.2014.03.00524786594
   PubMed Web of Science ®Google Scholar
• SullivanSD, RamseySD, LeeTA. The economic burden of COPD. Chest. 2000;117:5S–9S. doi:10.1378/chest.117.2_suppl.5S10673466
   PubMed Web of Science ®Google Scholar
• DalalAA, ShahM, D’SouzaAO, RanePJ. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med. 2011;105:454–460. doi:10.1016/j.rmed.2010.09.00320869226
   PubMed Web of Science ®Google Scholar
• CavaillèsA, Brinchault-RabinG, DixmierA, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22:454–475. doi:10.1183/09059180.0000861224293462
   PubMedGoogle Scholar
• CelliB, MacNeeW, AgustiA. ATS/ERS TASK FORCE Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946. doi:10.1183/09031936.04.0001430415219010
   PubMed Web of Science ®Google Scholar
• JohanssonG, MushnikovV, BäckströmT, et al. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study. BMC Pulm Med. 2018;18:17. doi:10.1186/s12890-018-0573-029370846
   PubMed Web of Science ®Google Scholar
• PauwelsRA, BuistAS, CalverleyPM, JenkinsCR, HurdSS, MedicineCC. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276. doi:10.1164/ajrccm.163.5.210103911316667
   PubMedGoogle Scholar
• García-PoloC, Alcázar-NavarreteB, Ruiz-IturriagaLA, et al. Factors associated with high healthcare resource utilisation among COPD patients. Respir Med. 2012;106:1734–1742. doi:10.1016/j.rmed.2012.09.00923058483
   PubMed Web of Science ®Google Scholar
• Dal NegroR, CelliB. Patient Related Outcomes-BODE (PRO-BODE): a composite index incorporating health utilization resources predicts mortality and economic cost of COPD in real life. Respir Med. 2017;131:175–178. doi:10.1016/j.rmed.2017.08.01928947025
   PubMed Web of Science ®Google Scholar
• BuX, YangT, ThompsonM, HutchinsonAF, IrvingL. Changes in the BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients. Singapore Med J. 2011;52:894–900.22159933
   PubMed Web of Science ®Google Scholar